The Montreal Clinical Research Institute (IRCM) and Sidney-Altman RNA Therapeutic Hub, in collaboration with McGill’s Center for RNA Sciences and Université de Montréal, invite you to the RNA Medicine & Innovation (RMedI) Symposium, which will take place at the IRCM on May 23 and 24. This symposium will bring together participants from academia and industry to discuss the latest advances in RNA biology and its transformative applications in therapeutics.
During the symposium, esteemed researchers, scientists, and experts will delve into the intricacies of RNA biology, exploring its multifaceted roles in gene regulation, protein synthesis, and disease. From RNA interference (siRNA) and antisense oligonucleotides (ASO) to messenger RNAs (mRNA) and Lipid Nanoparticles (LNP) delivery, the symposium will showcase the latest breakthroughs driving therapeutic development and revolutionizing medical treatment paradigms. A discussion panel involving various community stakeholders will also be held to discuss the strategies, challenges, and development of RNA technologies in Quebec and Canada.
To attend the symposium, please click here to Register.
Would you like to present your work in the form of a scientific poster? Submit an abstract here!
Symposium themes:
- RNA in disease
- RNA regulation and engineering
- RNA targeting modalities
Organizers:
- Dr. Mohamad-Gabriel Alameh, University of Pennsylvania / RNA Technologies and Therapeutics inc
- Dr. Thomas Duchaine, McGill University
- Dr. Éric Lécuyer, Institut de recherches cliniques de Montréal / Université de Montréal
- Dr. Marlene Oeffinger, Institut de recherches cliniques de Montréal / Université de Montréal
- Dr. Martin Sauvageau, Institut de recherches cliniques de Montréal / Université de Montréal
Keynote speakers:
- Dr. Nahum Sonenberg, McGill University
- Dr. Frank Slack, Harvard Medical School, BIDMC
Other guest speakers:
- Dr Nabil Seidah, Institut de Recherches Cliniques de Montréal
- Dr Mohamad-Gabriel Alameh, University of Pennsylvania / RNA Technologies and Therapeutics inc.
- Dr Galit Alter, Moderna
- Dr Karine Choquet, Université de Sherbrooke
- Dr. Yannick Cyr, NYU Langone
- Dr Masad Damha, McGill Centre for RNA Sciences
- Dr Steven Dowdy, University of California San Diego
- Dr Amanda Hargrove, University of Toronto Mississauga
- Dr Rabia Khan, Serna Bio
- Dr Maureen McKeague, McGill Center for RNA Sciences
- Dr Keith Pardee, University of Toronto
- Dr Bastien Paré, Oxford Nanopore Technologies
- Dr Christine Vande Velde, Centre Hospitalier de l’Université de Montréal
- Dr Maria Vera Ugalde, McGill University